Evidence map›Paper›PMID 31525580›Full record

ArticleInternational journal of medical informatics2019

Interrupting providers with clinical decision support to improve care for heart failure.

Saul Blecker, Jonathan S Austrian, Leora I Horwitz, Gilad Kuperman, Donna Shelley, Meg Ferrauiola, Stuart D Katz

Registry-linked trialAbstract read
In one paragraph

Article in International journal of medical informatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02858674 (Health Information Technology in Heart Failure Care), which is not on this map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02858674 nacompletednot on this map

Health Information Technology in Heart Failure Care

TypeinterventionalSponsorNYU Langone HealthRan2017 to 2018Enrolled958ConditionsHeart FailureArmsPop Up Interruption Alert, Side Bar Non Interruptive Provider Checklist
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Interruptive Electronic Alerts for Choosing Wisely Recommendations: A Cluster Randomized Controlled Trial.Journal of the American Medical Informatics Association : JAMIA · 2022
    Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Saul BleckerDepartment of Population Health, NYU School of Medicine, New York, NY, United States; Department of Medicine, NYU School of Medicine, New York, NY, United States; Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York, NY, United States. Electronic address: Saul.blecker@nyumc.org.
Jonathan S AustrianDepartment of Medicine, NYU School of Medicine, New York, NY, United States; Medical Center Information Technology, NYU Langone Health, New York, NY, United States.
Leora I HorwitzDepartment of Population Health, NYU School of Medicine, New York, NY, United States; Department of Medicine, NYU School of Medicine, New York, NY, United States; Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York, NY, United States.
Gilad KupermanMemorial Sloane Kettering Cancer Center, New York, NY, United States.
Donna ShelleyDepartment of Population Health, NYU School of Medicine, New York, NY, United States; Department of Medicine, NYU School of Medicine, New York, NY, United States.
Meg FerrauiolaMedical Center Information Technology, NYU Langone Health, New York, NY, United States.
Stuart D KatzDepartment of Medicine, NYU School of Medicine, New York, NY, United States.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Health Information Technology in Heart Failure CareK08HS023683 · AHRQ · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BLECKER, SAUL B. · 2014 to 2017
$633k
AHRQ HHS K08 HS023683NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

backgroundEvidence-based therapy for heart failure remains underutilized at hospital discharge, particularly for patients with heart failure who are hospitalized for another cause. We developed clinical decision support (CDS) to recommend an angiotensin converting enzyme (ACE) inhibitor during hospitalization to promote its continuation at discharge. The CDS was designed to be implemented in both interruptive and non-interruptive versions.

objectivesTo compare the effectiveness and implementation of interruptive and non-interruptive versions of a CDS to improve care for heart failure.

methodsHospitalizations of patients with reduced ejection fraction were pseudo-randomized to deliver interruptive or non-interruptive CDS alerts to providers based on even or odd medical record number. We compared discharge utilization of an ACE inhibitor or angiotensin receptor blocker (ARB) for these two implementation approaches. We also assessed adoption and implementation fidelity of the CDS.

resultsOf 958 hospitalizations, interruptive alert hospitalizations had higher rates of discharge utilization of ACE inhibitors or ARBs than non-interruptive alert hospitalizations (79.6% vs. 74.2%, p = 0.05). Utilization was higher for interruptive alert versus non-interruptive alert hospitalizations which were principally for causes other than heart failure (79.8% vs. 73.4%; p = 0.05) but no difference was observed among hospitalizations with a principal heart failure diagnosis (85.9% vs.81.7%; p = 0.49). As compared to non-interruptive hospitalizations, interruptive alert hospitalizations were more likely to have had: an alert with any response (40.6% vs. 13.1%, p < 0.001), contraindications reported (33.1% vs 11.3%, p < 0.001), and an ACE inhibitor ordered within twelve hours of the alert (17.6% vs 10.3%, p < 0.01). The response rate for the interruptive alert was 1.7%, and a median (25

conclusionsA CDS implemented as an interruptive alert was associated with improved quality of care for heart failure. Whether the potential benefits of CDS in improving cardiovascular care were worth the high burden of interruptive alerts deserves further consideration. CLINICALTRIALS. GOV IDENTIFIER: NCT02858674.

Indexed as

AgedAngiotensin-Converting Enzyme InhibitorsDecision Support Systems, ClinicalFemaleHeart FailureHospitalizationHumansMaleMedical Order Entry SystemsMedication ErrorsPatient SafetyPractice Patterns, Physicians'Angiotensin-Converting Enzyme InhibitorsClinical decision supportComparative effectivenessHeart failure

Identifiers

PMID31525580
PMCPMC6994190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.